MedPath

Sedation of midazolam and ketamine with propofol and ketamine in endoscopy

Phase 3
Conditions
sedation for endoscopy.
Registration Number
IRCT20200610047723N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
128
Inclusion Criteria

Having a body mass index between 21 and 24
Satisfaction to enter the study
The patient is a candidate for endoscopy

Exclusion Criteria

Have a history of high blood pressure, diabetes, respiratory failure and liver and kidney disease, and a history of addiction, heart disease and drug dependence.
Simultaneous use of some painkillers during endoscopy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: One hour after the procedure. Method of measurement: (VAS) Visual analoge scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath